524590 HEMORGANIC

Hemo Organic Share Price

₹13.40 +0.5 (3.88%)

28 Dec, 2024 17:11

SIP TrendupStart SIP in HEMORGANIC

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 17.75%
  • Over 3 Month + 10.56%
  • Over 6 Month + 14.92%
  • Over 1 Year + 78.43%
SIP Lightning

Smart Investing Starts Here Start SIP with Hemo Organic for Steady Growth!

Invest Now

Hemo Organic Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Hemo Organic Financials

Hemo Organic Technicals

EMA & SMA

Current Price
₹13.40
+ 0.5 (3.88%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹11.90
  • 50 Day
  • ₹11.50
  • 100 Day
  • ₹11.32
  • 200 Day
  • ₹11.51

Resistance and Support

13.29 Pivot Speed
  • R3 14.48
  • R2 14.09
  • R1 13.68
  • S1 12.88
  • S2 12.49
  • S3 12.08

What's your outlook on Hemo Organic?

You can only vote for once

Hemo Organic Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-12-26 Rights issue of Equity Shares
2024-10-28 Quarterly Results
2024-08-12 Quarterly Results
2024-05-29 Audited Results
2024-02-12 Quarterly Results

Hemo Organic F&O

Hemo Organic Shareholding Pattern

No data available.

About Hemo Organic

  • NSE Symbol
  • HEMORGANIC
  • BSE Symbol
  • 524590
  • ISIN
  • INE422G01015

Similar Stocks to Hemo Organic

Hemo Organic FAQs

Hemo Organic share price is ₹13 As on 28 December, 2024 | 16:57

The Market Cap of Hemo Organic is ₹4.6 Cr As on 28 December, 2024 | 16:57

The P/E ratio of Hemo Organic is -14.7 As on 28 December, 2024 | 16:57

The PB ratio of Hemo Organic is -14.7 As on 28 December, 2024 | 16:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23